financetom
Business
financetom
/
Business
/
IonQ Insider Sold Shares Worth $2,078,100, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
IonQ Insider Sold Shares Worth $2,078,100, According to a Recent SEC Filing
Jul 8, 2025 12:45 AM

03:20 AM EDT, 07/08/2025 (MT Newswires) -- Rima Alameddine, Chief Revenue Officer, on July 07, 2025, sold 45,000 shares in IonQ ( IONQ ) for $2,078,100. Following the Form 4 filing with the SEC, Alameddine has control over a total of 552,592 common shares of the company, with 552,592 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1824920/000095017025094417/xslF345X05/ownership.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BriaCell Reports Longer Overall Survival Rate in Phase 2 Breast Cancer Study
BriaCell Reports Longer Overall Survival Rate in Phase 2 Breast Cancer Study
Sep 11, 2024
08:58 AM EDT, 09/11/2024 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) on Wednesday announced positive overall survival rate in its Phase 2 study of Bria-IMT with an immune check point inhibitor (CPI) in late stage metastatic breast cancer. The most recent patients reported a median overall survival of 15.6 months (treated since 2022) compared with 6.7-9.3 months for similar...
Boohoo's prettylittlething brings back free returns ahead of holidays
Boohoo's prettylittlething brings back free returns ahead of holidays
Sep 11, 2024
LONDON, Sept 11 (Reuters) - The returning boss of Boohoo-owned online fashion retailer prettylittlething.com is bringing back free returns ahead of the holiday season, accepting a drain on profitability widely viewed as necessary to be competitive. On Tuesday, Umar Kamani, prettylittlething.com's (PLT) founder who left the business in 2023, announced his return on X and said: one of my first...
FDA staff raises efficacy concerns over Intercept's liver disease drug
FDA staff raises efficacy concerns over Intercept's liver disease drug
Sep 11, 2024
Sept 11 (Reuters) - The U.S. Food and Drug Administration's staff on Wednesday raised efficacy concerns over Intercept Pharmaceuticals' liver disease drug, which is awaiting traditional approval. The reviewers, in briefing documents published on the FDA's website, said the confirmatory trial for the drug did not provide evidence that it was effective in patients with a rare condition called primary...
AbbVie's Botox Cosmetic Launches in China for Masseter Muscle Prominence
AbbVie's Botox Cosmetic Launches in China for Masseter Muscle Prominence
Sep 11, 2024
08:55 AM EDT, 09/11/2024 (MT Newswires) -- AbbVie's ( ABBV ) Allergan Aesthetics said on Wednesday that Botox cosmetic is now available in China to treat masseter muscle prominence in adults. The company said Botox Cosmetic, recently approved by China's health regulatory agency, is the first neurotoxin approved in China for masseter muscle prominence. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved